These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28918054)

  • 1. Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology.
    Kruspe S; Dickey DD; Urak KT; Blanco GN; Miller MJ; Clark KC; Burghardt E; Gutierrez WR; Phadke SD; Kamboj S; Ginader T; Smith BJ; Grimm SK; Schappet J; Ozer H; Thomas A; McNamara JO; Chan CH; Giangrande PH
    Mol Ther Nucleic Acids; 2017 Sep; 8():542-557. PubMed ID: 28918054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
    Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
    Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE; Allan AL
    Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
    Liu YK; Hu BS; Li ZL; He X; Li Y; Lu LG
    Hepatol Int; 2016 Jul; 10(4):640-6. PubMed ID: 27115761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in lung cancer.
    Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
    Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
    Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity.
    McInnes LM; Jacobson N; Redfern A; Dowling A; Thompson EW; Saunders CM
    Front Oncol; 2015; 5():42. PubMed ID: 25767772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.
    O'Shannessy DJ; Davis DW; Anderes K; Somers EB
    Biomark Insights; 2016; 11():7-18. PubMed ID: 26848256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients.
    Zhang S; Wu T; Peng X; Liu J; Liu F; Wu S; Liu S; Dong Y; Xie S; Ma S
    Cancer Manag Res; 2017; 9():691-700. PubMed ID: 29200889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression.
    Satelli A; Batth I; Brownlee Z; Mitra A; Zhou S; Noh H; Rojas CR; Li H; Meng QH; Li S
    Oncotarget; 2017 Jul; 8(30):49329-49337. PubMed ID: 28521303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications.
    Jie XX; Zhang XY; Xu CJ
    Oncotarget; 2017 Oct; 8(46):81558-81571. PubMed ID: 29113414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.